The Safety and Effectiveness of Taneasy and Actein in COPD Patients

Exclusion Criteria

• •1. Subjects with known hypersensitivity to Acetylcysteine preparations.
• •2. Subjects with other serious medical diseases that are judged by the attending physician to affect the evaluation results (such as: tuberculosis, pneumonia, bronchial asthma, bronchiectasis, cor pulmonale, lung cancer, acute myocardial infarction, acute hepatitis, renal failure, etc.)
• •3. Pregnancy or breast-feeding woman.
• •4. Female subjects or their sexual partners do not use contraception during the trial.
• •5. Joining any drug clinical trial within 3 months prior to dosing.
• •6. Investigator considered to be inappropriate for enrollment.
• •7. Phenylketonuria (PKU).